Skip to content

Effect of sevoflurane inhalation anesthesia on perioperative myocardial action in elderly patients undergoing thoracoscopic surgery

Effect of sevoflurane inhalation anesthesia on perioperative myocardial action in elderly patients undergoing thoracoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058041
Enrollment
Unknown
Registered
2022-03-27
Start date
2022-03-15
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Sevoflurane group (Sev group):Anesthesia was maintained by continuous inhalation of 1% to 3% sevoflurane
Propofol group (Pro group):Pump propofol 3 ~ 4mg/ (kg·h)

Sponsors

The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to 84 Years

Inclusion criteria

Inclusion criteria: Elderly patients undergoing elective thoracoscopic lung cancer surgery, regardless of gender, aged 70-84 years, weight 45.5-74.5 Kg, ASA grade II or ?.

Exclusion criteria

Exclusion criteria: 1. Patients with myocardial infarction in recent half a year; 2. There are serious cerebrovascular diseases; 3. A history of endocrine diseases such as hyperthyroidism; 4. History of allergy to study drugs or allergic diseases; 5. Preoperative cTnI, CK-MB and BNP levels exceeded the normal range; 6. Patients who have used sevoflurane or hormones within 1 month before surgery.

Design outcomes

Primary

MeasureTime frame
Markers of myocardial injury;

Secondary

MeasureTime frame
Hemodynamics;

Countries

China

Contacts

Public ContactZheng Lihua

The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People's Hospital)

qzzhenglh@163.com+86 13205705553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026